OpenVSafe by OpenVAERS
Search V-safe

JU7-30441-37081

2 vaccinations 1 coded response 1 check-in 1 free-text entry 1 call case
Sex
Female
Age at first dose
16-20
ZIP prefix
009 / PR
Registered
2021-11-09
Relationship
Child or adolescent in my care
Guardian
C49-22222-01279
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-26
    Dose 2 — Pfizer-BioNTech
  3. 2021-11-09
    Registered in v-safe
  4. 2022-04-27
    Survey response — 12 months, dose 2, dependent
    MedDRA: Headache, Nasal congestion, Oropharyngeal pain, Pyrexia, Sensitive skin — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms began on February 21, 2022. Nasal congestion, sore throat, mild headache, mild fever, mild body/skin sensitivity. Before that and after, I have been ok.
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-04-27
    Report sent to call center — 12 months, dose 2, dependent
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  6. 2022-04-28
  7. 2022-04-29
  8. 2022-04-29

Vaccinations

DoseDateManufacturerCo-administered
12021-04-05Pfizer-BioNTech No
22021-04-26Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — 12 months, dose 2, dependent

2022-04-27

Symptoms: Symptoms began on February 21, 2022. Nasal congestion, sore throat, mild headache, mild fever, mild body/skin sensitivity. Before that and after, I have been ok.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDSensitive skin · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release